Special Issue on "Hepatitis C in the Middle East and North Africa"

Middle East and North Africa (MENA) region has the highest prevalence and burden of hepatitis C worldwide. While there is great ambition toward elimination of hepatitis C worldwide, most of MENA countries are far from achieving the hepatitis C elimination goals. One of the obstacles is the lack of reliable scientific evidences on epidemiologic, virologic and clinical aspects of hepatitis C needed for policy making and advocacy of health interventions.
This Special Issue of Hepatitis Monthly invites all researchers in MENA region to submit their studies on hepatitis C to help the regional elimination of hepatitis C. The editorial board would offer 40% discount on all manuscripts accepted for this special issue. The submission for this special issue is open at https://hepatmon.kowsarpub.com/en/user/login

Special Issue Theme:

  • Elimination of hepatitis C in MENA

Topics of particular interest:

  • Epidemiology of hepatitis C in special populations (e.g. PWID, FSW, thalassemia, etc.)
  • Molecular epidemiology of hepatitis C
  • Efficacy and safety of hepatitis C direct-acting antivirals
  • Hepatitis C resistance to direct-acting antivirals
  • Hepatitis C model of care in special populations
  • Micro-elimination and elimination of hepatitis C
  • Management of hepatic and extra-hepatic complications of hepatitis C
  • Burden of hepatitis C advanced liver diseases

Article types:

  • Original articles
  • Brief reports
  • Review articles
  • Letter to editors

Editor-in-chief:

  • Seyed Moayed Alavian, Middle East Liver Diseases Center, Iran; Email: [email protected]

Guest associate editors:

Submission deadline:

  • 30 September, 2021